Maldives bans Aciloc injection batch over quality issues
It is manufactured by Kadila Pharmaceutical Limited (Ahmedabad) of India.
Top Stories
-
Ihusaan says police will show bodycam footage from ministry fire
-
ACC seeks charges against ex-MPL CEO over MVR 1.08M AC purchase
-
Faisal meets Solih for talks on MDP 2028 presidential race
-
Thinadhoo mayor faces new case as ACC seeks more charges
-
6 Bangladeshis held for 10 days over suspected money laundering
Maldives Food and Drug Authority (MFDA) on Tuesday banned the use of specific batches of imported injections due to quality issues.
According to the authority, quality issues have been found in batch number RP21311 of Aciloc (Ranitidine injections) imported and used in the Maldives.
The MFDA banned the import, sale and use of the batch number.
According to MFDA:
-
It is manufactured by Kadila Pharmaceutical Limited (Ahmedabad) of India
-
If the batch found to be causing the problem is located in any pharmacy or health care facility, it should be notified
-
Recently, cough syrups manufactured by an Indian pharmaceutical company were also banned in the country
Related
Related
31 students treated for food poisoning at Addu camp
MFDA bans falsified batch of cancer drug Opdivo found in Maldives
Importing medicines without permit to carry fines of MVR 10,000
